Martin G Sanda
Martin G Sanda
Professor and Chairman of Urology, Emory University School of Medicine
Adresă de e-mail confirmată pe emory.edu - Pagina de pornire
Citat de
Citat de
The polycomb group protein EZH2 is involved in progression of prostate cancer
S Varambally, SM Dhanasekaran, M Zhou, TR Barrette, C Kumar-Sinha, ...
Nature 419 (6907), 624-629, 2002
Quality of life and satisfaction with outcome among prostate-cancer survivors
MG Sanda, RL Dunn, J Michalski, HM Sandler, L Northouse, L Hembroff, ...
New England Journal of Medicine 358 (12), 1250-1261, 2008
Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer
JT Wei, RL Dunn, MS Litwin, HM Sandler, MG Sanda
Urology 56 (6), 899-905, 2000
α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer
MA Rubin, M Zhou, SM Dhanasekaran, S Varambally, TR Barrette, ...
Jama 287 (13), 1662-1670, 2002
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part I: risk stratification, shared decision making, and care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ...
The Journal of urology 199 (3), 683-690, 2018
Autoantibody signatures in prostate cancer
X Wang, J Yu, A Sreekumar, S Varambally, R Shen, D Giacherio, R Mehra, ...
New England Journal of Medicine 353 (12), 1224-1235, 2005
Standard operating procedures for serum and plasma collection: early detection research network consensus statement standard operating procedure integration working group
MK Tuck, DW Chan, D Chia, AK Godwin, WE Grizzle, KE Krueger, W Rom, ...
Journal of proteome research 8 (1), 113-117, 2009
Contemporary diagnosis and management of renal angiomyolipoma
CP Nelson, MG Sanda
The Journal of urology 168 (4 Part 1), 1315-1325, 2002
A multicenter study of [-2] pro-prostate specific antigen combined with prostate specific antigen and free prostate specific antigen for prostate cancer detection in the 2.0 to …
WJ Catalona, AW Partin, MG Sanda, JT Wei, GG Klee, CH Bangma, ...
The Journal of urology 185 (5), 1650-1655, 2011
Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte …
JW Simons, B Mikhak, JF Chang, AM DeMarzo, MA Carducci, M Lim, ...
Cancer research 59 (20), 5160-5168, 1999
Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer
JT Wei, RL Dunn, HM Sandler, PW McLaughlin, JE Montie, MS Litwin, ...
Journal of Clinical Oncology 20 (2), 557-566, 2002
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
CS Jansen, N Prokhnevska, VA Master, MG Sanda, JW Carlisle, MA Bilen, ...
Nature 576 (7787), 465-470, 2019
Long-term outcomes among localized prostate cancer survivors: health-related quality-of-life changes after radical prostatectomy, external radiation, and brachytherapy
DC Miller, MG Sanda, RL Dunn, JE Montie, H Pimentel, HM Sandler, ...
Journal of Clinical Oncology 23 (12), 2772-2780, 2005
Urine TMPRSS2: ERG fusion transcript stratifies prostate cancer risk in men with elevated serum PSA
SA Tomlins, SMJ Aubin, J Siddiqui, RJ Lonigro, L Sefton-Miller, S Miick, ...
Science translational medicine 3 (94), 94ra72-94ra72, 2011
Development and validation of an abbreviated version of the expanded prostate cancer index composite instrument for measuring health-related quality of life among prostate …
KM Szymanski, JT Wei, RL Dunn, MG Sanda
Urology 76 (5), 1245-1250, 2010
Prospective assessment of patient reported urinary continence after radical prostatectomy
JT Wei, RL Dunn, R Marcovich, JE Montie, MG Sanda
The Journal of urology 164 (3 Part 1), 744-748, 2000
The TMPRSS2:ERG Rearrangement, ERG Expression, and Prostate Cancer Outcomes: A Cohort Study and Meta-analysis
A Pettersson, RE Graff, SR Bauer, MJ Pitt, RT Lis, EC Stack, NE Martin, ...
Cancer epidemiology, biomarkers & prevention 21 (9), 1497-1509, 2012
Clinically localized prostate cancer: AUA/ASTRO/SUO guideline. Part II: recommended approaches and details of specific care options
MG Sanda, JA Cadeddu, E Kirkby, RC Chen, T Crispino, J Fontanarosa, ...
The Journal of urology 199 (4), 990-997, 2018
Multiplex biomarker approach for determining risk of prostate-specific antigen-defined recurrence of prostate cancer
DR Rhodes, MG Sanda, AP Otte, AM Chinnaiyan, MA Rubin
Journal of the National Cancer Institute 95 (9), 661-668, 2003
Prediction of erectile function following treatment for prostate cancer
M Alemozaffar, MM Regan, MR Cooperberg, JT Wei, JM Michalski, ...
Jama 306 (11), 1205-1214, 2011
Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.
Articole 1–20